These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17458534)

  • 1. [Botulinum toxin A injection for treatment-refractory giggle incontinence].
    Wefer B; Seif C; van der Horst C; Jünemann KP; Braun PM
    Urologe A; 2007 Jul; 46(7):773-5. PubMed ID: 17458534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin treatment for bladder dysfunction.
    Santos-Silva A; da Silva CM; Cruz F
    Int J Urol; 2013 Oct; 20(10):956-62. PubMed ID: 23634720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it reasonable to treat refractory voiding dysfunction in children with botulinum-A toxin?
    Radojicic ZI; Perovic SV; Milic NM
    J Urol; 2006 Jul; 176(1):332-6; discussion 336. PubMed ID: 16753436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.
    Prescrire Int; 2013 Jan; 22(134):12-3. PubMed ID: 23367677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children.
    Franco I; Landau-Dyer L; Isom-Batz G; Collett T; Reda EF
    J Urol; 2007 Oct; 178(4 Pt 2):1775-9; discussion 1779-80. PubMed ID: 17707430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
    Kuo HC
    Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravesical treatment of overactive bladder syndrome].
    Haferkamp A; Hohenfellner M
    Urologe A; 2006 Oct; 45(10):1283-8. PubMed ID: 16972089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity.
    Kuo HC
    J Urol; 2007 Oct; 178(4 Pt 1):1359-63. PubMed ID: 17706718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate for giggle incontinence.
    Berry AK; Zderic S; Carr M
    J Urol; 2009 Oct; 182(4 Suppl):2028-32. PubMed ID: 19695642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics.
    Kuo HC
    Urology; 2005 Jul; 66(1):94-8. PubMed ID: 15992869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravesical botulinum neurotoxin-A injection on detrusor hyperreflexia in spinal cord injured patients.
    Ge XT; Li YF; Wang Q; Zhao JN
    Drug Res (Stuttg); 2015 Jun; 65(6):327-31. PubMed ID: 25350080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment for giggle incontinence with biofeedback.
    Richardson I; Palmer LS
    J Urol; 2009 Oct; 182(4 Suppl):2062-6. PubMed ID: 19695635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of botulinum toxin injection for neurogenic detrusor overactivity: Switch of toxin versus second injection of the same toxin.
    Peyronnet B; Castel-Lacanal E; Manunta A; Roumiguié M; Marque P; Rischmann P; Gamé X
    Int J Urol; 2015 Dec; 22(12):1160-5. PubMed ID: 26391575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giggle incontinence in children: a manifestation of detrusor instability.
    Chandra M; Saharia R; Shi Q; Hill V
    J Urol; 2002 Nov; 168(5):2184-7; discussion 2187. PubMed ID: 12394756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions.
    Bagi P; Biering-Sørensen F
    Scand J Urol Nephrol; 2004; 38(6):495-8. PubMed ID: 15841785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.
    Reitz A; Stöhrer M; Kramer G; Del Popolo G; Chartier-Kastler E; Pannek J; Burgdörfer H; Göcking K; Madersbacher H; Schumacher S; Richter R; von Tobel J; Schurch B
    Eur Urol; 2004 Apr; 45(4):510-5. PubMed ID: 15041117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biofeedback treatment of giggle incontinence in a teenager].
    Krzemińska K; Maternik M; Zurowska AM
    Pol Merkur Lekarski; 2009 Sep; 27(159):236-8. PubMed ID: 19827738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The quality of life of patients with overactive bladder after local injections of botulinum toxin A--a preliminary report].
    Rechberger T; Miotła P; Skorupski P; Wróbel A; Tomaszewski J
    Ginekol Pol; 2010 Jan; 81(1):24-30. PubMed ID: 20232695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.